Electromedical Technologies, Inc Financial Ratios
EMED|FY2023 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2023 SEC 10-K data.
Key Data Points
- Altman Z-Score -40.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2023)
Return on Equity
-
Profit Margin
-195.8%
Net Income / Revenue
Asset Turnover
1.80
Revenue / Total Assets
Equity Multiplier
-0.26
Total Assets / Equity
Profitability
Liquidity
Current Ratio
0.13
Quick Ratio
0.11
Solvency
Interest Coverage
-1.59
Efficiency
Asset Turnover
1.80
Inventory Turnover
4.43
Days Sales Outstanding
1 days
As of FY2023 · SEC 10-K · Updated Jun 29, 2026
Earnings Quality
Accrual Ratio
-116.5%
+82.7pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.